首页> 外文期刊>PLoS One >The Neurokinin 1 Receptor Antagonist, Ezlopitant, Reduces Appetitive Responding for Sucrose and Ethanol
【24h】

The Neurokinin 1 Receptor Antagonist, Ezlopitant, Reduces Appetitive Responding for Sucrose and Ethanol

机译:Neurokinin 1受体拮抗剂,依洛匹坦,减少对蔗糖和乙醇的食性响应

获取原文
           

摘要

Background The current obesity epidemic is thought to be partly driven by over-consumption of sugar-sweetened diets and soft drinks. Loss-of-control over eating and addiction to drugs of abuse share overlapping brain mechanisms including changes in motivational drive, such that stimuli that are often no longer ‘liked’ are still intensely ‘wanted’ [7], . The neurokinin 1 (NK1) receptor system has been implicated in both learned appetitive behaviors and addiction to alcohol and opioids; however, its role in natural reward seeking remains unknown. Methodology/Principal Findings We sought to determine whether the NK1-receptor system plays a role in the reinforcing properties of sucrose using a novel selective and clinically safe NK1-receptor antagonist, ezlopitant (CJ-11,974), in three animal models of sucrose consumption and seeking. Furthermore, we compared the effect of ezlopitant on ethanol consumption and seeking in rodents. The NK1-receptor antagonist, ezlopitant decreased appetitive responding for sucrose more potently than for ethanol using an operant self-administration protocol without affecting general locomotor activity. To further evaluate the selectivity of the NK1-receptor antagonist in decreasing consumption of sweetened solutions, we compared the effects of ezlopitant on water, saccharin-, and sodium chloride (NaCl) solution consumption. Ezlopitant decreased intake of saccharin but had no effect on water or salty solution consumption. Conclusions/Significance The present study indicates that the NK1-receptor may be a part of a common pathway regulating the self-administration, motivational and reinforcing aspects of sweetened solutions, regardless of caloric value, and those of substances of abuse. Additionally, these results indicate that the NK1-receptor system may serve as a therapeutic target for obesity induced by over-consumption of natural reinforcers.
机译:背景技术当前的肥胖流行被认为部分是由于过量食用含糖饮食和软饮料。饮食失控和滥用药物成瘾具有重叠的大脑机制,包括动机驱动力的改变,使得通常不再被“喜欢”的刺激仍然强烈地“想要” [7]。神经激肽1(NK1)受体系统与学习到的食欲行为以及酒精和阿片类药物的成瘾有关;但是,其在自然奖励中的作用仍然未知。方法/主要发现我们试图在三种食用蔗糖和食用蔗糖的动物模型中,使用新型选择性且临床安全的NK1-受体拮抗剂ezlopitant(CJ-11,974),确定NK1-受体系统是否在蔗糖的增强特性中起作用。寻找。此外,我们比较了ezlopitant对乙醇消耗和啮齿类动物觅食的影响。使用有效的自我给药方案,NK1受体拮抗剂ezlopitant对蔗糖的食欲响应比乙醇更有效,而不会影响一般的运动活性。为了进一步评估NK1受体拮抗剂在减少甜味溶液消耗中的选择性,我们比较了依洛匹坦对水,糖精和氯化钠(NaCl)溶液消耗的影响。 Ezlopitant减少了糖精的摄入,但对水或盐溶液的消耗没有影响。结论/意义本研究表明,NK1受体可能是调节甜味溶液的自我管理,激励和强化方面的一条常见途径的一部分,而与热量和滥用物质无关。此外,这些结果表明,NK1受体系统可以作为由过度摄取天然增强剂引起的肥胖症的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号